Skip to content

Evaluation of the preventive effect of anti-inflammatory drugs in extractions of third molars.

Comparative evaluation of the anti-inflammatory effect of Ibuprofen, Etodolac, Loxoprofen, and Dexamethasone associated with preemptive analgesia, in lower third molar Surgeries

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-8rfwnq
Enrollment
Unknown
Registered
2019-09-20
Start date
2014-01-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tooth Extraction

Interventions

After selection, the patients were divided into three groups according to the orally administered preoperative medication: 1 - DEX 8 mg (Laboratório Teuto Brasileiro s/a – 17159229000176, Brazil, Anáp
Drug
Procedure/surgery
Q65.070

Sponsors

Faculdade de Odontologia campus de Araçatuba unesp
Lead Sponsor
Faculdade de Odontologia campus de Araçatuba unesp
Collaborator

Eligibility

Age
16 Years to 35 Years

Inclusion criteria

Inclusion criteria: Participants met the inclusion criteria determined by means of anamnesis, clinical, and radiographic examinations. Included patients comprised those in good systemic and general health condition, between 16 and 35 years of age, and those with an indication of lower third molar (#38 or 48) removal, with at least 2/3 of the root formed, according to the radiographic evaluation (Class I or II; Position A/B from Pell & Gregory, 1942).

Exclusion criteria

Exclusion criteria: Participant exclusion criteria was also obtained by means of anamnesis, clinical, and radiographic examinations 6- 8- 9- 11- 14- 23- 24; they included all the opposite questions regarding the inclusion criteria plus the individuals who used any drug in the 30 days prior to the surgical procedure, and female patients during menstrual, gestational, or lactation periods.

Design outcomes

Primary

MeasureTime frame
This study aimed to evaluate the effect of preemptive analgesia between the association of non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids and the use of corticosteroids alone, after extraction of third molars. It is expected that the association of the two types of anti-inflammatory drugs (NSAIDs and corticosteroids) will be able to reduce postoperative pain, assessed by analogue visual scale (VAS) analysis in periods of 6, 12, 24, 48, 72 hours and 7 days, in which the patient reports the sensation of postoperative pain choosing a value for the sensation of 0 to 10 in a subjective spectrum. Postoperative pain will also be assessed using the number of rescue analgesics consumed, which represents the amount of analgesics the patient reported need to consume according to the pain they felt. It is also expected that the combination of anti-inflammatories will reduce postoperative edema, which will be evaluated by measuring craniometric points related to edema in the 48-hour and 7-day periods. The reduction of postoperative trismus is also expected from the association of anti-inflammatory drugs. This parameter will be evaluated through the linear measurement of the patient's oral opening, represented by the interincisal distance of the patient.;Outcomes found: With regard to postoperative pain, it was possible to observe that the association between anti-inflammatory drugs (NSAIDs and corticosteroids) reduced postoperative pain related to analysis through the visual analogue scale, as well as, reduced the consumption of analgesics of rescue in the postoperative period. Edema also showed reduction in all periods for the association of anti-inflammatories. However, trismus did not present the expected outcome, remaining at higher values ??for the association of anti-inflammatory drugs

Secondary

MeasureTime frame
Secondary outcomes are not expected.

Countries

Brazil

Contacts

Public ContactFabio Miranda

Faculdade de Odontologia campus de Araçatuba unesp

fvmpatologia@yahoo.com.br+55(18)36363237

Outcome results

None listed

Source: REBEC (via WHO ICTRP)